The global DNA sequencing market to grow at a CAGR of 20.93% during the period 2018-2022.
Global DNA Sequencing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The latest trend gaining momentum in the market is growth of the bioinformatics tools that make DNA sequencing easy. DNA sequencing manufacturers are making measures to increase the affordability and executability of DNA sequencing. Due to this, the next generation sequencing market is witnessing the development of cost-effective and time-effective advanced products. The introduction of cost-effective and easy to handle sequencing bioinformatics DNA sequencing tools will further contribute to the market growth.
According to the report, one of the major drivers for this market is the all-inclusive cost structure of sequencing products. Manufacturers developed an all-inclusive cost approach, that includes the cost of components, direct costs, and indirect costs. This all-inclusive cost structure explains the cost structure to end-users and funding agencies. Also, this cost approach reduces the volume of sequencing and increase the volume of data. Detailed cost-related data decreases the cost of sequencing and that increases the amount of genome data for better research. Consequently, detailed cost structure is driving the demand for DNA sequencing in the next generation sequencing market.
Further, the report states that one of the major factors hindering the growth of this market is Difficulties in clinical interpretations and inadequate reimbursements. Challenges related to clinical samples can affect the growth of the market. A single exome sample can contain up to 20,000 variants, whereas a whole-genome sample will generally have more than three million. Hence, a patient may have to undergo several genetic tests before the disease-causing mutation is identified. This can become expensive and inconvenient for the patient.
F. Hoffmann-La Roche
Pacific Biosciences of California
Thermo Fisher Scientific
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
Market segmentation analysis
PART 05: MARKET SIZING
Market size and forecast
PART 06: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
PART 07: MARKET SEGMENTATION BY PRODUCT
Comparison by product
Global DNA sequencing market by services
Global DNA sequencing market by instruments, reagents, and consumables